Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 6/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1102475 | 0.91 | P2RX4 (0.39) | P2RX4MIFMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL15458030 | 0.88 | MIF (0.36) | MIFSMN1; SMN2NPSR1EGLN1KIF11 | |
| SCHEMBL20160867 | 0.88 | P2RX4 (0.37) | P2RX4MAPTSMN1; SMN2NPSR1CDK8 | |
| SCHEMBL13706095 | 0.85 | MGLL (0.46) | P2RX4MGLL | |
| SCHEMBL20935976 | 0.84 | P2RX4 (0.41) | P2RX4MAPTSMN1; SMN2NPSR1ALDH1A1 | |
| SCHEMBL17278485 | 0.82 | MAPT (0.39) | MIFMAPTSMN1; SMN2EGLN1LMNA | |
| SCHEMBL1102443 | 0.80 | MGLL (0.39) | MIFMAPTSMN1; SMN2NPSR1EGLN1 | |
| SCHEMBL29379993 | 0.80 | P2RX4 (0.47) | P2RX4NPSR1ALDH1A1MGLL | |
| SCHEMBL29406608 | 0.80 | P2RX4 (0.47) | P2RX4NPSR1ALDH1A1MGLL | |
| SCHEMBL1573992 | 0.80 | P2RX4 (0.47) | P2RX4NPSR1ALDH1A1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-04-25 | — | — | US | disclosed |
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
| US-10580996-B2 | Polycyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20180148640-A1 | DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, CLTB, CYBA | P2RX4 1164/4885MIF 462/4885MAPT 102/4885 |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY2, NR2E3, CRY1 | P2RX4 1277/4885MIF 3838/4885MAPT 530/4885 |
| US-20180148640-A1 | DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | DCX, TERT, TELO2 | P2RX4 3135/4885MIF 2682/4885MAPT 1276/4885 |
| US-10580996-B2 | Polycyclic compound and organic light-emitting element comprising same | CRY2, NR2E3, CRY1 | P2RX4 1277/4885MIF 3838/4885MAPT 530/4885 |
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, CLTB, CYBA | P2RX4 1164/4885MIF 462/4885MAPT 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.